Studies have shown that the expression of USP3 is significantly elevated in several cancers, including gastric cancer [8], lung cancer [9] and colorectal cancer [10], and that high expression of USP3 is closely associated with poor patient prognosis. This evidence concerns the gene USP3 and lung cancer.